Close Menu

Give Us the Money

Nuvelo and Arca Biopharma announced yesterday that they will be merging to make a late-stage cardiovascular biotechnology company. Nuvelo's alfimeprase, a drug to treat blood clots, failed last year but Nuvelo retained $76 million. This is an example, says Reuters, of failed or failing biotechs being taken over for access to their excess cash.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Seven individuals have been named to the President's Council of Advisors on Science and Technology, ScienceInsider reports.

Retraction Watch reports that a series of tweets led to expression of concern for a PLOS Genetics paper, a move the paper's authors disagree with.

Researchers have sequenced pumas from North and South America to enable better identification of inbreeding, Cosmos magazine reports.

In Nucleic Acids Research this week: ways to find cell death or proliferation signatures, Han Chinese population genome database, and more.